BUDGET IMPACT ANALYSIS OF THE USE OF ASPART INSULIN DURING HOSPITALIZATION OF PATIENTS WITH HYPERGLYCAEMIA IN ITALY

被引：0
|
作者：
Iannazzo, S. [1 ]
Pradelli, L. [1 ]
Montagnoli, R. [2 ]
Militano, L. [2 ]
机构：
[1] AdRes HE&OR, Turin, Italy
[2] Novo Nordisk Farmaceut Spa, Rome, Italy
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1327
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A475 / A476
页数：2
相关论文
共 50 条
  • [41] BUDGET IMPACT ANALYSIS OF SARGRAMOSTIM USE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA
    Toy, E. L.
    Porter, C. L.
    Books, P.
    Vekeman, F.
    Barghout, V
    Duh, M.
    Skarin, A. T.
    VALUE IN HEALTH, 2009, 12 (03) : A39 - A39
  • [42] Budget impact analysis of sargramostim use in patients with chemotherapy-induced neutropenia
    Duh, M.
    Toy, E. L.
    Porter, C. L.
    Books, P. L.
    Vekeman, F.
    Barghout, V.
    Skarin, A. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Comparison of in vitro stability at needle end of insulin aspart and insulin glulisine during simulated use in infusion pumps
    Senstius, Jakob
    Poulsen, Christian
    Hvass, Aage
    DIABETES, 2006, 55 : A455 - A455
  • [44] Budget impact analysis of insulin therapies and associated delivery systems
    Lee, Lauren J.
    Smolen, Lee J.
    Klein, Timothy M.
    Foster, Shonda A.
    Whiteman, Doug
    Jorgenson, James A.
    Hultgren, Steve
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (11) : 958 - 965
  • [45] Intravenous Use of Insulin Aspart: Observational Data from a Large Population of Hospitalised Patients
    Udwadia, Farokh
    Bhattacharyya, Arpandev
    Seshaiah, V.
    Sethi, Bipin K.
    Kumar, Surender
    Subbanna, P. K.
    Moharana, Ashok K.
    Moses, Anand
    DIABETES, 2009, 58 : A530 - A531
  • [46] UPDATE ON THE USE OF INSULIN ASPART IN PATIENTS WITH DIABETES: ADDITIONAL ADVANTAGES IN DIFFERENT CLINICAL CONTEXTS
    Javier Ampudia-Blasco, F.
    AVANCES EN DIABETOLOGIA, 2012, 28 : 1 - 2
  • [47] Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Niu, Yan-Li
    Zhang, Ye
    Song, Zhi-Yong
    Zhao, Chuan-Zhi
    Luo, Yun
    Wang, Yan
    Yuan, Jing
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (02) : 313 - 322
  • [48] Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy
    Iannazzo, Sergio
    Mannucci, Edoardo
    Mantovani, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (01) : 19 - 27
  • [49] Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis
    Rosti, Giovanni
    Lebboroni, Maria
    Cerchiari, Ario
    Katz, Pablo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2011, 12 (03) : 119 - 127
  • [50] BUDGET IMPACT ANALYSIS OF INHALED LOXAPINE FOR THE MANAGEMENT OF PSYCHOMOTOR AGITATION IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER IN ITALY
    Viti, R.
    Marcellusi, A.
    Bini, C.
    Mennini, F. S.
    VALUE IN HEALTH, 2018, 21 : S278 - S278
12345